Moderna eyes third quarter for first doses of potential COVID-19 vaccine with Catalent deal - Reuters

Moderna Inc said on Thursday it was partnering with contract drugmaker Catalent Inc to prepare an initial 100 million doses of its coronavirus vaccine for the United States, starting in the third quarter of this year. https://www.reuters.com/article/us-health-coronavirus-moderna-catalent-idUSKBN23W1SI